CALCAREA PHOSPHORICA

N/A

Manufactured by ANI Pharmaceuticals, Inc.

70 FDA adverse event reports analyzed

Last updated: 2026-04-15

About CALCAREA PHOSPHORICA

CALCAREA PHOSPHORICA is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by ANI Pharmaceuticals, Inc.. The most commonly reported adverse reactions for CALCAREA PHOSPHORICA include ASTHENIA, BALANCE DISORDER, DEPRESSION, DIARRHOEA, DYSPNOEA. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CALCAREA PHOSPHORICA.

Top Adverse Reactions

ASTHENIA3 reports
BALANCE DISORDER3 reports
DEPRESSION3 reports
DIARRHOEA3 reports
DYSPNOEA3 reports
GAIT DISTURBANCE3 reports
HAEMOGLOBIN DECREASED3 reports
HALLUCINATION3 reports
HEART RATE INCREASED3 reports
HEMIPARESIS3 reports
INFUSION RELATED REACTION3 reports
MOBILITY DECREASED3 reports
MOVEMENT DISORDER3 reports
MUSCULAR WEAKNESS3 reports
PULMONARY EMBOLISM3 reports
RASH3 reports
SCAB3 reports
SEIZURE3 reports
SKIN ABRASION3 reports
SPEECH DISORDER3 reports
VOMITING3 reports
WEIGHT DECREASED3 reports
DISEASE PROGRESSION1 reports
DRUG EFFECT INCOMPLETE1 reports
DRUG INEFFECTIVE1 reports
NEOPLASM RECURRENCE1 reports

Report Outcomes

Out of 3 classified reports for CALCAREA PHOSPHORICA:

Serious 100.0%Non-Serious 0.0%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Male3 (100.0%)

Reports by Age

Age 453 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with CALCAREA PHOSPHORICA?

This profile reflects 70 FDA FAERS reports that mention CALCAREA PHOSPHORICA. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for CALCAREA PHOSPHORICA?

Frequently reported terms in FAERS include ASTHENIA, BALANCE DISORDER, DEPRESSION, DIARRHOEA, DYSPNOEA, GAIT DISTURBANCE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures CALCAREA PHOSPHORICA?

Labeling and FAERS entries often list ANI Pharmaceuticals, Inc. in connection with CALCAREA PHOSPHORICA. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.